Program Overview
Supporting people who use substances in shelter settings during the COVID-19 pandemic
Supporting people who use substances in acute care settings during the COVID-19 pandemic
Topic
Emergency care
Applying a Modified Version of the Prediction of Alcohol Withdrawal Severity Scale in a Canadian Community Withdrawal Management Setting
Crepeault H, Cowan N, Socias ME, Riazi N, Knill A, Khela A, Wood E, Ti L., Drug Alcohol Rev. 2025
“You kind of blame it on the alcohol, but. . .”: A discourse analysis of alcohol use and sexual consent among young men in Vancouver, Canada
Goodyear T, Oliffe JL, Kia H, Jenkins EK, Knight R., Health (London). 2025
Mental Health and Dispositional Predictors of Simultaneous Versus Concurrent Cannabis and Alcohol Use in a Canadian Context
Vieira JL, Coelho SG, Snaychuk LA, Tabri N, Dawson SJ, Hodgins DC, Keough MT, Shead NW, Kim HS., Cannabis, 2024
Examining the association between public health unit spending and adolescent substance use
Rai U, Patte KA, Smith BT, Senthilselvan A, Hyshka E, Leatherdale ST, Pabayo R., Heliyon, 2024
How Experiences of Stigma and Discrimination at Various Points in the Queer Life Course Interrelate with Alcohol Use: Views from Sexually and Gender Diverse Youth
Flores-Aranda J, Gaudette Y, Dalle A, Nadeau D, Goyette M. Int J Environ Res Public Health. 2024
Development and validation of the perceived approval of risky drinking inventory in undergraduate students
Hines S.A., Morin A.J.S., Norman P., Read J.P., O’Connor R.M., Psychology of Addictive Behaviors, 2024
decriminalisation
Harm reduction
Law enforcement/incarceration
Temporal and regional associations between fentanyl concentrations in the unregulated drug supply and drug-related mortality in British Columbia, Canada
Tobias S, Bird J, Guzman SM, Palis H, Crabtree A, Hein JE, Wood E, Ti L., Canada. Int J Drug Policy. 2026
Slow-Release Oral Morphine vs Methadone for Opioid Use Disorder in the Fentanyl Era
Socias ME, Lei J, Zhou V, Anand R, Cui Z, Penta S, Larochelle M, Lodi S, Fairbairn N., AMA Netw Open. 2026
Development and validation of a fentanyl quantification model for drug checking services
Tobias S, Guzman SM, Hein JE, Ti L., Drug Alcohol Depend Rep. 2026
Predicting Fatal Drug Poisoning Among People Living with HIV‑HCV Co‑Infection
Mélanie Bédard, Erica Em Moodie, Joseph Cox, John Gill, Sharon Walmsley, Valérie Martel‑Laferrière, Curtis Cooper, Marina B Klein, Canadian Liver Journal, 2025
Longitudinal polysubstance use patterns and non-fatal overdose: a repeated measures latent class analysis
Karamouzian M, Cui Z, Hayashi K, DeBeck K, Reddon H, Buxton J, Kerr T, Int J Drug Policy
A qualitative study exploring motives for the transition from injecting to smoking drugs in Vancouver, British Columbia
Bonn M, Kerr T, Boyd J, Rudzinski K, McNeil R, Ivsins A., Int J Drug Policy. 2025
Opioid agonist treatment
Prescription monitoring
The stakes of stimulant use, psychosis, and antipsychotic treatment among youth who use drugs: A longitudinal qualitative study
Goodyear T, Thulien M, Anghel A, Slemon A, Jensen M, Ignaszewski MJ, Sassi R, Mathias S, Jenkins E, Knight R, Fast D. , Soc Sci Med. 2025
Exploring unregulated substance use health data in Ontario, Canada: Identifying gaps, addressing challenges, and uncovering opportunities
Ali, F., Law, J., Russell, C., Imtiaz, S., Bayoumi, A., Werb, D., Rhem, J., Front. Public Health
Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020
Jackson E, Bach P, Socias ME, Brooks OM, Fairbairn N, Rodrigues M, Rosic T, Naji L, Jinks-Chang S, Nolan S, Chesney A, Reshetukha T, Samaan Z, Dennis BB., Drug Alcohol Depend. 2025
Comparative Effectiveness of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use Among People with Opioid Use Disorder in Canada
Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME., Subst Use Addctn J. 2025
